Why the study?
CIED infections remain life-threatening despite advances in device design, infection control, and antibiotic prophylaxis, necessitating updated clinical guidance.
This American Heart Association scientific statement provides updated recommendations for the epidemiology, risk factors, microbiology, management, and prevention of CIED infections.
Guides CIED infection management with explicit recommendations now; extends prior statements and prioritizes research gaps.
Despite improvements in cardiovascular implantable electronic device (CIED) design, application of timely infection control practices, and administration of antibiotic prophylaxis at the time of device placement, CIED infections continue to occur and can be life-threatening. This has prompted the study of all aspects of CIED infections. Recognizing the recent advances in our understanding of the epidemiology, risk factors, microbiology, management, and prevention of CIED infections, the American Heart Association commissioned this scientific statement to educate clinicians about CIED infections, provide explicit recommendations for the care of patients with suspected or established CIED infections, and highlight areas of needed research.
No takes yet. Share an insight, caveat, or question.
Baddour et al. (2010) conducted a review in Cardiovascular implantable electronic device (CIED) infections. Management and prevention of CIED infections was evaluated. This American Heart Association scientific statement provides updated recommendations for the care of patients with suspected or established cardiovascular implantable electronic device infections.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: